A powerful test for multiple rare variants association studies that incorporates sequencing qualities by Daye, Z. John et al.
A powerful test for multiple rare variants
association studies that incorporates
sequencing qualities
Z. John Daye
1, Hongzhe Li
1 and Zhi Wei
2,*
1Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia,
PA 19104, USA and
2Department of Computer Science, New Jersey Institute of Technology, Newark,
NJ 07102, USA
Received October 28, 2011; Revised December 20, 2011; Accepted January 4, 2012
ABSTRACT
Next-generation sequencing data will soon become
routinely available for association studies between
complex traits and rare variants. Sequencing data,
however, are characterized by the presence of
sequencing errors at each individual genotype.
This makes it especially challenging to perform
association studies of rare variants, which, due to
their low minor allele frequencies, can be easily
perturbed by genotype errors. In this article, we
develop the quality-weighted multivariate score as-
sociation test (qMSAT), a new procedure that allows
powerful association tests between complex traits
and multiple rare variants under the presence of
sequencing errors. Simulation results based on
quality scores from real data show that the qMSAT
often dominates over current methods, that do not
utilize quality information. In particular, the qMSAT
can dramatically increase power over existing
methods under moderate sample sizes and rela-
tively low coverage. Moreover, in an obesity data
study, we identified using the qMSAT two functional
regions (MGLL promoter and MGLL 30-untranslated
region) where rare variants are associated with
extreme obesity. Due to the high cost of sequencing
data, the qMSAT is especially valuable for large-
scale studies involving rare variants, as it can
potentially increase power without additional
experimental cost. qMSAT is freely available at
http://qmsat.sourceforge.net/.
INTRODUCTION
Analysis of common variants through genome-wide asso-
ciation (GWA) studies has enjoyed much success over the
last few years. More than a thousand genetic loci
associated with more than 200 complex traits have been
identiﬁed (1). However, these variants typically explain
only a small fraction of the inheritable variability for
common diseases (2). This may, in part, be explained by
the genetic theory that implicates natural selection in
pruning out disease-causing variants efﬁciently before
they may become common among the population (3).
On the other hand, rare variants, having minor allele
frequencies (MAFs) between 0.1 and 1%, are often
evolved from more recent mutations and less subjected
to natural selection. Thus, association studies of rare
variants may hold the potential for identifying genetic
components that are functionally relevant and causal for
a larger proportion of inheritable variability (4–6). Several
studies have already demonstrated the relevance of rare
variants on complex traits (7–13). The availability of
emerging sequencing technologies will soon allow associ-
ation studies to be routinely performed between complex
traits and rare variants, making the development of robust
and powerful procedures for rare variants association es-
pecially relevant.
Recent studies reveal several important characteristics
of rare variants association. The rare variant hypothesis
states that a large proportion of common diseases may
be due to the aggregate effects of multiple rare variants,
acting independently and with detectable effects on
disease risks (4,6,14). Due to low allele frequencies,
rare variants often do not exhibit strong linkage disequi-
librium (LD) with either rare or common SNPs (6,15).
Hence, GWA studies through indirect LD-mapping with
tagged SNPs are usually ineffective in detecting rare
variants. Rare variants identiﬁed in recent literatures
usually have strong effects with a mean odds ratio
(OR) of 3.74 and most variants having ORs greater
than 2 (4). This is quite different from the effects of
identiﬁed common variants, which usually have ORs
between 1.1 and 1.4. Recent studies also present evi-
dences of multiple rare variants acting collectively on
disease risks (8,11,16).
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have been proposed for rare variants. These tests often
employ the idea of pooling or collapsing multiple rare
variants. This is partly due to the need to aggregate
effects of low-frequency variants in order to increase
power and further due to recent evidences suggesting
that multiple rare variants often act collectively upon
disease risks (8,11,16,17). For example, the combined
multivariate and collapsing (CMC) test (18) extends the
cohort allelic sum test (CAST) (17) by collapsing variants
in subgroups according to allele frequencies and
combining these subgroups using Hotelling’s T
2 test. The
step-up procedure determines whether each variant is pro-
tective, deleterious or non-causal and aggregates them ac-
cordingly (19). The C-alpha test is a homogeneity test for
case-control data via binomial proportions (20). The
sequence kernel association test (SKAT) extends kernel
machine-based tests for rare variants with more accurate
asymptotic approximations in the tail distribution (21).
Moreover, several popular multivariate tests for GWA
studies have been evaluated for rare variants association,
including the mininum of univariate P-values (UminP)
(22), sum score (23), sum of squared score (SSU) (24)
and weighted sum of squared score (SSUw) tests (25).
These existing methods can sometimes be limited for
rare variants association as they do not incorporate
sequencing quality information. Associating rare
variants to complex traits can be challenging due to the
presence of sequencing errors. Under low MAFs, a few
minor alleles mistaken as major or a few major alleles
mistaken as minor can both result in signiﬁcant loss of
power in rare variants association. The quality of individ-
ual genotype estimate can vary signiﬁcantly across both
variants and samples, even when the mean sequencing
coverage is high. Nevertheless, accurate measures of
sequencing qualities can be readily obtained for each
genotype using variant calling toolkits (26,27). Genotype
quality scores (GQ) are often provided in Phred scale with
GQ= 10 log10(1 Pr), where Pr is the probability of a
genotype being correctly called (28). Thus, a GQ value of
10 indicates a 10% sequencing error, whereas a value of 30
indicates 0.1% error. Incorporating sequencing qualities
in association tests may allow us to increase power and to
fully explore the potential of emerging sequencing
technologies for identifying causal rare variants.
Some existing methods allow the incorporation of prior
weights on each variant (21,24,29), which can potentially
incorporate average quality scores across variants.
However, sequencing qualities also vary signiﬁcantly
across samples, in addition to variants. For example, a
variant may consist of some proportion of high-quality
genotype samples but others that are sequenced at low
qualities, with the extreme case of having missing values.
Utilizing these genotypes without considering varying
sequencing qualities across samples can signiﬁcantly
decrease power in rare variants association studies due
to large perturbations from low-quality samples. Thus, a
new procedure is needed that can address the incorpor-
ation of sequencing qualities at each individual genotype.
To achieve a robust and powerful test for rare variants
association studies, we propose a quality-weighted
multivariate score association test (qMSAT) that directly
incorporates sequencing qualities in association tests with
multiple rare variants. The qMSAT utilizes a quality-
weighted multivariate regression model to incorporate
sequencing qualities at each individual genotype. It is
robust towards the inclusion of noncausal variants and
variants having effects with different magnitudes and dir-
ections. Furthermore, it can coherently account for
missing genotypes and conjoin in a principled way indi-
viduals and variants sequenced at varying coverage
depths. When no quality information is utilized, the
qMSAT is equivalent to the C-alpha, SSU and SKAT
using the linear kernel. The qMSAT is therefore
expected to perform equivalently or better than estab-
lished methods when quality information is utilized.
We present extensive simulation studies based upon
sequencing qualities from real data, obtained from the
1000 Genomes Project (30). To guide investigators, we
examine the performances of the qMSAT with current
methods across a spectrum of MAFs, odds ratios, coverage
depths, sample sizes and LD structures. We also provide
scenarios of having non-causal variants and variants
having effects with different magnitudes and directions.
These results suggest that the qMSAT can often dominate
over current methods, that do not utilize quality informa-
tion. In particular, the qMSAT often demonstrates signiﬁ-
cant improvements in power under moderate sample sizes
and relatively low coverage for rare variants association.
Furthermore, we apply the qMSAT in an application to
theUCSDobesitydatastudy,whereweidentiﬁedtwofunc-
tional regions, the MGLL promoter and MGLL
30-untranslated region (30-UTR), that exhibit signiﬁcant
multiple rare variants association with extreme obesity.
Most importantly, our results suggest the qMSAT to be a
potentially valuable tool for increasing power without
incurringadditionalexperimentalcosts,suchasbysequenc-
ing at higher coverage depths or larger sample sizes (31).
MATERIALS AND METHODS
Quality-Weighted Multivariate Score Association Test
(qMSAT)
In this article, we consider case-control association
studies having d multiple rare variants and n individuals.
For the i-th individual, yi denotes a dichotomous
trait with yi=1 for cases and yi=0 for controls and
Gi=(Gi1,..., Gid) are variant genotypes. We assume, in
this article, that genotypes are represented by the additive
geneticmodelwhereGij=0,1or2arethenumbersofminor
alleles at a locus. However, our procedure can be used
withothergeneticmodels,suchasthedominantorrecessive
model, and our conclusions regarding the inclusion of
quality information will remain the same using another
genotypic assignment.
Consider the logistic regression model,
logitPðyi ¼ 1Þ¼ 0 þ
X d
j¼1
 jGij ð1Þ
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j-th variant on trait. The rare variants hypothesis sug-
gests that rare variants often act independently on
disease risks. Further, having low MAFs, rare variants
usually do not exhibit strong LD, even at close proximity
(6,11,15). Hence, we consider a quality-weighted
log-likelihood,
lð 0; ; Þ¼
X n
i¼1
X d
j¼1
qij yi logpij þð 1   yiÞlogð1   pijÞ
  
ð2Þ
where
pij ¼ logit
 1ð 0 þ  jGijÞ
and qij are quality weights on each pair (i, j) of individuals
and variants. The quality-weighted log-likelihood (2)
utilizes relative independence among rare variants by
aggregating over weighted marginal likelihoods. It
allows effects of individual genotypes to be evaluated
based upon sequencing qualities, down-weighting those
having relatively low qualities. The weighted multivariate
log-likelihood approach has been utilized successfully in
several other statistical contexts (32,33). It is often
employed for the incorporation of quality-related con-
stituents (34). The approach enables conjoined analysis
of sequencing data over a spectrum of qualities and read
depths. Moreover, problems associated with imputing rare
variants for traditional association tests can be circum-
vented by assigning qij=0 at missing genotypes in
Equation (2). The quality-weighted likelihood naturally
allows missing genotypes without the need for imputation,
which can be quite challenging under low MAFs.
For simplicity, we utilize the genotype quality scores
directly as weights qij in this article. The quality-based
weights qij can also be assigned using the number of reads
and monotonically non-decreasing functions of quality
scores, such as qij ¼ð GQ=tÞIfGQ 5 tg+IfGQ   tg
where I{ } is an indicator function and t is some thresh-
old above which qualities are believed to be equally accept-
able. A myriad of quality-based weights can be applied
based upon an investigator’s preferences and prior
knowledge.
To achieve a robust and powerful test for multiple rare
variants association, we utilize a quality-weighted Rao’s
score statistic (35) in testing the multivariate null
hypothesis,
H0 :  1 ¼  2 ¼ ...¼  d ¼ 0: ð3Þ
Computing for the slope of the log-likelihood Equation
(2) with genotype coefﬁcients bj restricted at the null hy-
pothesis, we obtain the quality-weighted score vector
S=(S1, S2,..., Sd)
T where
Sj ¼
X n
i¼1
qijGij yi   ^ p0
ij
  
ð4Þ
and
^ p0
ij ¼
Pn
i¼1 qijyi Pn
i¼1 qij
are the predicted proportions of cases at the j-th variant.
We deﬁne the qMSAT statistic as the norm squared of
the quality-weighted score vector
qMSAT ¼ S
TS: ð5Þ
If no quality information is utilized (qij=1), the qMSAT
is reduced to the SSU and linear SKAT and is also equiva-
lent to the C-alpha test. The qMSAT provides a compu-
tationally efﬁcient means to estimate expected
improvements in model ﬁt according to sequencing
qualities when the null hypothesis in Equation (3) may
be violated. It admits a simple form as explicit computa-
tions of genotype coefﬁcients bj are not required. Utilizing
a quadratic form, the qMSAT is robust towards the inclu-
sion of variants having effects with opposing directions.
However, with prior weights imposed upon the responses
yi in Equation (2), the qMSAT statistic does not assume a
readily approximable asymptotic distribution. Thus, we
utilize a permutation-based strategy, where the distribu-
tion of the qMSAT statistic is approximated using statis-
tics computed with randomly re-sampled responses ~ yi in
Equation (4) (36). As asymptotic-based tests are not
guaranteed to be reliable under low MAFs and limited
sample sizes, permutation-based procedures are often
preferred in rare variants association studies (20,29).
Having a simple form, the qMSAT can be computed efﬁ-
ciently even when large numbers of permutations are
required. Indeed, the qMSAT is equivalent in computa-
tional speed to C-alpha and other score-based procedures,
that have been successfully employed in several earlier
studies (20,25,29).
Simulations
We present extensive simulations based upon sequencing
qualities from the Pilot Phase 3 study of the 1000
Genomes project (30). The study provides sequencing
data for 90 Caucasian individuals over 2385 rare variant
sites, amounting to 214650 genotype quality scores across
a spectrum of read depths. In order to compare perform-
ances of various methods under realistic error distribu-
tions, we sampled directly from these empirical quality
scores in generating simulated data.
We generated simulated data over a spectrum of MAFs,
odds ratios, coverage depths, sample sizes and LD struc-
tures. We also provided scenarios where non-causal
variants and variants having effects with different magni-
tudes and directions are included. As in previous studies
(25,37), we ﬁrst generated d latent variables from the
multivariate normal distribution with the autoregressive
covariance structure D= 
ji jj, where  =0 was used to
generate independent variants and   close to 1 was used to
generate variants in strong LD with its neighbors. The
latent variables were then used to produce a haplotype
at a given MAF by dichotomizing variables at a speciﬁed
quantile. Two independent haplotypes thus generated
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with which we generated dichotomous phenotypes for a
case–control study under the logistic regression model
logitPðyi ¼ 1Þ¼ 0 þ
X d
j¼1
 j ~ Gij ð6Þ
at given effect sizes bj or odds ratios exp(bj). The intercept
term a0 was set to attain a disease rate of 5%. As in con-
ventional case–control design, we randomly sampled n/2
cases and n/2 controls along with their underlying geno-
types ~ Gij. Next, we generated observed genotypes Gij by
perturbing the underlying ones ~ Gij with sequencing
qualities sampled from the 1000 Genomes project. At a
given mean coverage depth (dp), we simulated the number
of reads for each genotype from the gamma distribution
with shape and scale parameters at 6.3 and dp/6.3, respect-
ively. The gamma distribution with the speciﬁed param-
eters have been found to approximate observed numbers
of reads well from mean coverage in previous studies
(38,39). The quality score GQ was obtained for each
genotype by sampling from quality scores of the 214650
Pilot Phase 3 study genotypes with an observed number of
reads equal to or closest to the number of reads simulated
from mean coverage. Finally, we generated genotypes Gij
by randomly perturbing ~ Gij using the Bernoulli distribu-
tion with error probabilities 10
( GQ/10). Each procedure
was applied by associating phenotypes yi with perturbed
genotypes Gij. Sampled quality scores at each genotype
were utilized as weights qij in the qMSAT.
We compared the qMSAT with 10 other methods that
have been proposed recently for rare variants association.
The SSU, SSUw, Score, SKAT with linear and quadratic
kernels, and UminP are score-based procedures similar to
the qMSAT, whereas the Sum and CMC tests are derived
from estimates in a logistic regression with collapsed
variants. The step-up procedure also performs variable
selection to determine causality and directions of effects
in addition to collapsing variants together. The C-alpha
procedure is a homogeneity test based upon binomial pro-
portions. In a case–control study, the C-alpha is equiva-
lent to the SSU and linear SKAT (21,40). Moreover, the
C-alpha, SSU and linear SKAT are, in turn, equivalent to
the qMSAT if no quality information is utilized (qij=1).
We implemented the qMSAT in R, available online at
http://qmsat.sourceforge.net/. The SSU, SSUw and Score
tests were computed using R codes from an earlier study
(24), whereas the SKAT was computed using the R
package from the original paper (21). The SKAT
package also includes options for incorporating MAF-
based weights on each variant. Nonetheless, in order to
clearly demonstrate the effects of MAF on association
tests, our simulations were performed at a spectrum of
values at ﬁxed MAFs. Incorporating MAF-based weight
on each variant is only beneﬁcial if both rare and common
variants are included. Thus, we do not incorporate
MAF-based weights for the SKAT in this study. The
thgenetics R package was used for the step-up proced-
ure (19). All other procedures were computed using avail-
able codes in a recent study (40). P-values for the qMSAT,
C-alpha, and step-up procedures were computed using 500
permutations. Simulated data for type I errors were
generated using the restricted logistic regression model
instead of (6),
logitPðyi ¼ 1Þ¼ 0;
where ORs were set to 1 for each variant. Both empirical
powers and type I errors for each procedure were
estimated using 1000 repetitions as the proportion of
P-values<0.05.
Application to UCSD obesity data set
We analyzed a targeted re-sequencing data of candidate
genes at extreme obesity levels from the UCSD obesity
study (41,42). The data set consisted of 289 individuals
of European ancestry; among which, 73 men and 70
women having body mass index (BMI)  40 kg/m
2 were
selected as cases, and 74 men and 72 women with
BMI 30 kg/m
2 were assigned as controls. Two intervals
were sequenced over 188 kb that encompassed regions
encoding the endocannabinoid metabolic enzymes,
fatty-acid amide hydrolase (FAAH) and monoglyceride
lipase (MGLL). Earlier studies had found genes in the
endocannabinoid system that regulates obesity levels
(43,44), making the FAAH and MGLL prime candidates
for association analysis of variants to extreme obesity.
We mapped short reads using the Burrows-Wheeler
Alignment (BWA) algorithm (45). We employed the
most recent state-of-the-art variant calling toolkit
GATK (26) to perform variant calls and extract corres-
ponding quality scores at each genotype. An earlier algo-
rithm MAQ (46) was used in the original study (42)
for variant calling. We obtained 977 variants with a
mean coverage of 101 . These variants were then
annotated using SeattleSeq (http://gvs.gs.washington
.edu/SeattleSeqAnnotation/). Given the annotations, we
focused on the 455 rare variants that were not cataloged
in the dbSNP database (47); these variants were then
divided based on their genomic positions into groups of
promoters, 50-UTRs, exon regions, intron regions and
30-UTRs, for performing association tests. For each
gene, we combined all exon variants together in a group
and considered only non-synonymous variants. The
FAAH promoter was sequenced over the 11.5 kb
upstream region, whereas the MGLL promoter encom-
passed the 12.5 kb upstream region. Short functional
regions with less than two variants were not included in
this study. Missing genotypes were imputed by sampling
randomly from non-missing ones in the same variant, and
their associated quality scores were set to be 0. Number of
permutations in statistical tests was increased to 10000 for
increased precision in P-values.
RESULTS
Presence of sequencing errors
Figure 1 presents sequencing qualities of the data from the
Pilot Phase 3 study of the 1000 Genomes project at each
genotype in terms of genotype quality scores (GQ) and
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coverage depths. The quantities are related through the
conversion formula Pr=1 10
 GQ/10. We observe that
sequencing qualities tend to increase with increasing
coverage depths or numbers of reads at a genotype.
Nonetheless, even at relatively high coverage depths, a
signiﬁcant proportion of genotypes still assumes low
sequencing qualities. For example, the 99% interval
includes genotypes with GQ=15 (or 1 Pr=0.03) at a
coverage depth of 20 . In association analysis of rare
variants where MAFs are low, even a small proportion
of unaccounted sequencing errors can inﬂuence results un-
expectedly. In the following studies, we evaluate the effects
of having sequencing errors under realistic settings by
sampling sequencing qualities directly from the Pilot
Phase 3 study as presented in Figure 1 (see ‘Material
and Methods’ section).
Evaluation of the effects of coverage depth and
sample size
We evaluated empirical powers and type I errors over
mean coverage depths of 5 ,1 0  ,2 0  ,3 0  ,5 0   and
100  and moderate sample sizes of 200, 400, 600, 800
and 1000, each having balanced numbers of cases and
controls. We considered 20 rare variants (d=20) consist-
ing of ﬁve causal ones with odds ratios of 2, 3, 4, 0.5 and
0.5 for power computations. No LD was assumed among
the variants. In each case, we compared the qMSAT with
10 other methods that do not utilize quality information
(see ‘Material and Methods’ section).
Figure 2 presents type I errors at an MAF of 0.5%.
Type I errors are generally well controlled. However,
score-based procedures using asymptotic distributions
(SSU, SSUw, Score, SKAT and UminP) tend to be con-
servative at moderate or high coverage, especially when
sample sizes are small. On the other hand, permutation-
based methods (qMSAT, C-alpha and step-up) are usually
well controlled around the 0.05 error rate. This may
suggest that permutation methods can sometimes be ad-
vantageous under ﬁnite samples. Supplementary Figures
S1 and S3 further depict type I errors at MAFs of 0.1%
and 1%, respectively.
Empirical powers are provided in Figure 3 at an MAF
of 0.5%. We observe that the qMSAT often dominates
over other procedures, that do not utilize quality informa-
tion. Improvements in power are most signiﬁcant at rela-
tively low coverage. Consider the permutation-based
C-alpha, which is related to the qMSAT when no
quality information is utilized (see ‘Material and
Methods’ section). At n=600, the qMSAT outperforms
C-alpha with 78.0, 158, 61.2, 27.4, 21.0 and 14.8% in-
creases in power at mean coverage depths of 5 ,1 0  ,
20 ,3 0  ,5 0  , and 100 , respectively (Figure 3).
Moreover, the qMSAT often achieves fairly high powers
even at relatively low coverage. At n=1000, the qMSAT
attains powers of 0.530, 0.739 and 0.773 at mean coverage
depths of 10 ,2 0   and 30 , respectively, whereas a
similar level of power is attained at 0.780 with a much
higher mean coverage depth of 100  (Figure 3). This
suggests the qMSAT as a valuable tool for achieving
powerful results without incurring additional costs, such
as by sequencing at higher coverage depths. The SSU
usually tends to have higher powers than SSUw and
score tests. Previous studies have suggested that the
SSUw and score tests that depend upon accurate
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Figure 1. Genotype sequencing qualities generated in Pilot Study 3 of the 1000 Genomes Project. Sequencing qualities in terms of genotype quality
scores (GQ) and probability of sequencing errors (1 Pr) are displayed, where 1 Pr=10
 GQ/10. A total of 2385 rare variants are called, amounting
to 214650 genotypes at various coverage depths. (a) Plot of sequencing qualities at all genotypes, with coverage depths spaced logarithmically.
(b) Modiﬁed box plot of genotypes at coverage depths of 5 ,1 0  ,2 0  ,3 0  ,5 0   and 100 . Short, bold lines are drawn at the median.
Each whisker ends at the 1 and 99% quantiles, and each box encloses the 5–95% interval.
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spectively, may be limited for multivariate analysis when
the dimension d is large (24,48,49). The SKAT using linear
kernels often has higher powers than the SKAT using
quadratic kernels as epistatic effects were not included in
this analysis. Due to the inclusion of causal variants
having opposing directions, the sum test often has
limited powers. Supplementary Figures S2 and S4
further provide power evaluations at MAFs of 0.1 and
1%, respectively.
Evaluation of the effects of MAF and odds ratio
We compared empirical powers and type I errors over
varying MAFs of 0.1, 0.5, 1, 5 and 10% and ORs of 1–6
for each of the ﬁve variants among the 20 (d=20) con-
sidered, in which the remaining are non-causal with ORs
of 1. Identiﬁed rare variants in recent literatures have a
mean OR of 3.74, and most have ORs greater than 2 (4).
To focus on evaluating effects of MAF and OR, we con-
sidered n=500 observations with balanced numbers of
cases and controls and assumed no LD among the
variants.
Figure 4 presents empirical powers and type I errors
(ORs=1) at a mean coverage depth of 30 . Power in-
creases for all methods with increasing MAF and OR. The
qMSAT often outperforms other procedures at low MAFs
for rare variants, whereas all procedures do well at high
MAFs for common variants. For low MAFs, power for
the qMSAT improves dramatically for increasing ORs.
For example, at an MAF of 0.1%, the qMSAT outper-
forms C-alpha with 66.0, 84.4, 113, 124 and 127% in-
creases in power at causal variants’ ORs of 2, 3, 4, 5
and 6, respectively (Figure 4). This may suggest the
qMSAT as a potentially useful procedure for identifying
rare variants (with MAFs between 0.1 and 1%) under
moderate sample sizes and, possibly, for identifying
novel variants (with MAFs <0.1%) having strong effect
sizes in large-scale studies. The sum test performs competi-
tively with related methods in this example, as all causal
variants have the same direction. Supplementary Figures
S5–S9 present empirical powers and type I errors at mean
coverage depths of 5 ,1 0  ,2 0  ,5 0   and 100 , respect-
ively. Improvements of the qMSAT tend to be more pro-
nounced at lower coverage depths in this example.
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Figure 2. Type I errors over varying coverage depths and sample sizes at MAF=0.5%. There are n/2 numbers of cases and controls each. Twenty
non-causal rare variants (d=20) are considered with odds ratios at 1 for all variants. No LD is assumed among the variants. Reference lines (in red)
are drawn at the 0.05 error rate.
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We evaluated the effects of LD at a mean coverage depth
of 30  and sample sizes of n=500, with equal numbers of
cases and controls. A spectrum of LD structures was
evaluated with latent variables having autoregressive co-
variance matrices D= 
ji jj with   at 0, 0.25, 0.5, 0.75 and
0.9 (Figure 5). We employed 20 variants (d=20) with
ORs of (3, 2, 1, 1, 4, 1, 1, 1, 0.5, 0.5, 1,...,1). Variants
generated with  =0 are independent, whereas those
generated with large values of   are in LD with its
neighbors.
Figure 5 presents empirical powers for evaluating
LD effects. Power increases for all methods with increasing
  or degree of LD among neighboring variants. This is
largely because variants in LD tend to have effect sizes
augmented by aggregation. The qMSAT tends to
dominate other methods at relatively low MAFs, even at
high LD. Rare variants usually do not exhibit strong LD
(6,11,15). However, these results suggest that the qMSAT
can also be effective when LD effects are strong.
Supplementary Figure S10 further provides type I errors.
Application to UCSD obesity data set
We analyzed the UCSD obsesity data from a previous
study that suggested multiple rare variants to be
associated with the FAAH promoter, the MGLL
promoter, and a region of MGLL introns (42). We per-
formed multiple rare variants association tests using all
statistical approaches as above. As in the original study
(42), none of these methods found signiﬁcant rare variants
in the FAAH and MGLL exon regions (Supplementary
Table S1); several methods conﬁrmed associations of
multiple rare variants in the FAAH promoter and
MGLL promoter regions (Table 1). Speciﬁcally, the
qMSAT attained P-values of 0.061 and 0.037 for the
FAAH promoter and MGLL promoter regions, respect-
ively. No intron regions were found to be signiﬁcant by
any of these methods (Supplementary Table S1).
Interestingly, several methods, including the qMSAT
(Table 1), identiﬁed the MGLL 30-UTR to be signiﬁcant,
which was missed in the previous study (42). Promoters
are well known to be gene transcription regulators that
specify binding of transcription factors to DNA
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Figure 3. Power evaluation of the effects of coverage depths and sample sizes at MAF=0.5%. There are n/2 numbers of cases and controls each.
Twenty rare variants (d=20) are considered, of which ﬁve are causal with odds ratios at 2, 3, 4, 0.5 and 0.5. No LD is assumed among the variants.
PAGE 7 OF 12 Nucleic AcidsResearch, 2012, Vol.40,No. 8 e60sequences. Moreover, protein binding to 30-UTR is known
to function in some situations by protecting mRNA from
nuclease degradation (50). These results suggest that
recent mutations in the FAAH promoter, MGLL
promoter, and MGLL 30-UTR may have led to extreme
obesity levels in some individuals by altering gene tran-
scription mechanisms. Further studies, such as by
associating rare variants to gene expression levels, may
help to verify these results. On the other hand, recent mu-
tations in MGLL introns might not have played as signiﬁ-
cant a role as previous study (42) suggested in extreme
obesity. Differences between our results from those of
the previous study might be due to using more recent
variant calling algorithm in our analysis (see ‘Material
and Methods’ section). Among the procedures evaluated,
the qMSAT has the smallest P-values for association of
rare variants in the MGLL promoter and MGLL 30-UTR
with extreme obesity levels (Table 1). The C-alpha, SSU
and linear SKAT are equivalent to the qMSAT when no
quality information is utilized. Both C-alpha and qMSAT
utilize a permutation-based estimation of P-values in
order to better control type I errors under moderate
samples. In all three regions where at least one method
indicates signiﬁcant association, the qMSAT has signiﬁ-
cantly smaller P-values than the C-alpha (Table 1). These
results conﬁrm our simulation studies suggesting that the
incorporation of quality information can often improve
power in rare variants association analysis. We observe
that the SKAT using linear kernels has smaller P-values
than the SKAT using quadratic kernels (Table 1). This
may suggest that rare variants, having low MAFs, might
not be able to exhibit strong interaction and higher-order
effects. In addition, we performed marginal association
analysis of rare variants in the FAAH promoter, MGLL
promoter and MGLL 30-UTR (Supplementary Table S2).
The MGLL promoter contains two variants with marginal
associations signiﬁcant at the 0.05 P-value level but with
opposing effects on extreme obesity (Supplementary Table
S2). In this region at the MGLL promoter, the multivari-
ate sum test has the largest P-value of 0.578 (Table 1).
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Figure 4. Effects of MAFs and odds ratios at a mean coverage depth of 30 . Empirical powers and type I errors are presented at a mean coverage
depth of 30  with varying MAFs and odds ratios for ﬁve variants amongst twenty (d=20) considered altogether. We use n=500 observations,
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e60 Nucleic Acids Research, 2012,Vol. 40,No. 8 PAGE 8 OF 12This may support previous studies asserting the sum test
to be limited when association of signiﬁcant variants in a
region are in opposite directions, though it might be
powerful when directions are the same (25). Due to low
MAFs, marginal association tests for rare variants often
have low power and can be subjected to perturbations
from genotype errors. Both the FAAH promoter and
MGLL 30-UTR, indicated to be signiﬁcant by several
multivariate tests, do not have rare variants exhibiting
marginal associations signiﬁcant at the 0.05 P-value level
(Supplementary Table S2). This result further suggests the
beneﬁt of pooling multiple variants together in identifying
rare variants associated with common diseases.
In this application, the qMSAT P-values were
computed in 25.039s for all 12 regions considered using
10000 permutations with the R programming language.
In large-scale rare variants association studies involving
hundreds of sequenced genes, it is expected to take only
a couple of hours. Computing speed can also be greatly
improved by using more efﬁcient programming languages,
such as C or Fortran. Among the methods evaluated, the
step-up procedure has comparatively much slower compu-
tational speed, as it has to ascertain whether each variant
is protective, deleterious or non-causal.
DISCUSSION
We have proposed a novel procedure that allows the in-
corporation of sequencing qualities directly in association
tests of complex traits and multiple rare variants.
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Figure 5. Power evaluation of the effects of linkage disequilibrium. Empirical powers are presented at a mean coverage depth of 30  and sample
sizes n=500 with equal numbers of cases and controls for a spectrum of LD structures generated from latent variables having autoregressive
covariance matrices D= 
ji jj. Variants generated with  =0 have no LD, whereas variants generated with large values of   are in high LD. Twenty
variants (d=20) are considered having odds ratios of (3, 2, 1, 1, 4, 1, 1, 1, 0.5, 0.5, 1,...,1).
Table 1. Multiple rare variants association analysis of the UCSD
obesity data
FAAH
promoter
(d=17)
MGLL
promoter
(d=25)
MGLL 30-UTR
(d=6)
qMSAT 0.061 0.037 0.002
C-alpha 0.077 0.049 0.044
SSU 0.080 0.038 0.246
SSUw 0.145 0.234 0.308
Score 0.146 0.123 0.303
SKAT (Linear) 0.079 0.038 0.246
SKAT (Quad) 0.107 0.050 0.250
UminP 0.631 0.211 0.627
Step up 0.022 0.063 0.015
Sum 0.002 0.578 0.052
CMC 0.015 0.109 0.052
P-values are provided for association tests performed over d multiple
rare variants. FAAH promoter, MGLL promoter and MGLL 30-UTR
are regions exhibiting signiﬁcant association of multiple rare variants
with extreme BMI at the 0.05 level by one or more methods. P-values
signiﬁcant at the 0.05 level are boldfaced.
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sampled directly from real data have been used to
evaluate our method across a spectrum of factors of
interest. Results have suggested the qMSAT as a poten-
tially very useful method for improving power, especially
under moderate sample sizes and relatively low coverage.
Moreover, our analysis of the UCSD obesity data set
using the qMSAT has identiﬁed two regions (MGLL
promoter and MGLL 30-UTR), where multiple rare
variants are signiﬁcantly associated with extreme obesity.
We have not considered the inclusion of additional
covariates in order to provide a concise presentation. It
is clear that our conclusions regarding the incorporation
of sequencing qualities will remain the same whether add-
itional covariates are included or not. The qMSAT can be
easily extended to include additional covariates, such as
relevant common variants and environmental effects. For
dichotomous traits yi and Xi a dc-vector of additional
covariates, the qMSAT statistic qMSAT=S
T S is
deﬁned using scores in Equation (4) with
^ p0
ij ¼ logit
 1ð^  
ðjÞ
0 þ XT
i ^  ðjÞÞ
where ^  
ðjÞ
0 and ^  ðjÞ are estimated under the null hypothesis
by maximizing the log-likelihood in Equation (2) with
pij ¼ logit
 1ð 0 þ XT
i   þ  jGijÞ using only the covariates
Xi and quality-based weights q1j, q2j,..., qnj at the j-th
variant, i.e. qij0 =0 for all i=1,..., n and j0 6¼j.
Moreover, we focused on association tests with the
logistic regression for case–control studies. This is partly
due to the prevalence of case–control data in biomedical
researches and the fact that effects of rare variants, having
extremely low MAFs, can be more readily modeled with
dichotomous traits than continuous ones. However, with
the advent of large-scale rare variants association studies
in the near future, quantitative traits may also be con-
sidered. For continuous traits yi, the qMSAT statistic is
deﬁned with scores
Sj ¼
X n
i¼1
qijGijðyi   ^  
ðjÞ
0   XT
i ^  ðjÞÞ;
for which the quality-weighted log-likelihood under the
linear model
lð 0; ; Þ¼ 
X n
i¼1
X d
j¼1
qijðyi    0   XT
i      jGijÞ
2
is employed in place of Equation (2). The coefﬁcients ^  
ðjÞ
0
and ^  ðjÞ are estimated under the null hypothesis by
weighted least squares regression of yi on additional
covariates Xi only with quality-based weights q1j, q2j,...,
qnj at the j-th variant. The same beneﬁts demonstrated for
the qMSAT for case–control data are expected to extend
to applications involving quantitative traits.
We have not considered association studies simultan-
eously involving both rare and common variants. A
common strategy proposed in the literature is to
re-weight each variant according to its MAF, augmenting
effects of rare variants relative to common ones. However,
it is not clear which is the best way to re-weight variants
objectively. For example, re-weighting by standard devi-
ations, control MAFs (51), and beta transformations of
MAFs (21) have been proposed. As rare variants usually
act on disease risks independently of common ones (6,15),
a natural approach is to ﬁrst identify common variants
that may be causal, such as by routine GWA studies,
and then incorporate them as additional covariates Xi as
in the qMSAT.
In this article, we have utilized genotype quality scores
as weights in the qMSAT. These scores can account for
errors, such as those arising from base calling in sequencer
traces and mapping of short sequencing reads, and can
quantify genotype uncertainty accurately at most loci.
However, variant calling at some loci may suffer due to
artifacts, such as from strand bias, that cannot be easily
accounted for and may lead to less accurate genotype
quality scores. Nonetheless, current variant calling
programs usually can ﬁlter out the variants at these sus-
picious loci (26,27,52). In the situation when genotype
qualities are less accurate, the qMSAT may be less
powerful while type I errors are expected to be controlled
due to permutation (36). Nevertheless, our results demon-
strate that the incorporation of sequencing qualities can
consistently improve power over methods that do not in-
corporate quality information. Moreover, the develop-
ment of variant calling methods is an active area
(26,27,52,53), and our procedure will continue to beneﬁt
from future improvements in variant calling programs.
On the other hand, the qMSAT is quite ﬂexible and can
incorporate other forms of weights, in addition to quality
information. For example, if there is evidence to believe
that some variants are more likely to be functional, such
as by prior knowledge or evolutionary models (54), or
some individuals are more representative of the effected
population, the qMSAT weights qij can be redeﬁned ac-
cordingly in order to incorporate additional informa-
tion at each variant or individual. Indeed, the qMSAT
extends earlier methods with weights on each variant
(24,51,55) to allow varying weights on both individuals
and variants.
Statistical analysis of sequencing data is ultimately
limited by inadequacies in the underlying technology
employed. With the qMSAT, we approached this chal-
lenge by incorporating sequencing quality, a technology-
derived constituent, directly in a statistical procedure. The
qMSAT also offers a coherent strategy for integrating
missing genotypes and individual genotypes sequenced at
varying coverage depths and quality scores. Improvements
in performances that we observed for the qMSAT in both
empirical and real-data studies may suggest the import-
ance of considering the limitations of the technology at
hand in order to improve statistical analysis of genomic
data sets.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables S1–S2 and Supplementary Figures
S1–S10.
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